Susi Geiger on Muck Rack

Susi Geiger

Dublin
As seen in: The Guardian, Wiley Online Library, Cambridge University Press & Assessment, Journal of Medical Ethics (JME), SAGE Publishing, Taylor & Francis Online, The Globe and Mail, European Journal of Marketing, Reader Supported News
Full Prof @UCDdublin. Principal Investigator @MISFIRES_ERC. Member @AccessToMedsIR. Yoga teacher. Activism, healthcare, markets, STS, sociology, digital health.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Susi

Contact Susi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

At the Crossroads of Data Justice and Data Capitalism: How Generative AI in Healthcare Mobilises Its Assemblages

|
By Nicole Gross, Susi Geiger
| Wiley Online Library
1 Introduction Ireland's new children's hospital, scheduled to open its doors in 2026, is announced to be the country's first ‘digital hospital’; its ‘digital first’ strategy encompasses digital technologies ranging from automated back-office processes to self-service kiosks to electronic health records to cybersecurity and automated guided vehicles delivering goods.
Open in Who Shared Issue with article?

Why Are Drug Prices So High in America? Trump Doesn’t Have the Right Answer

|
By Susi Geiger, Théo Bourgeron
| Reader Supported News
Americans are not paying high prices because of other western countries. Pharmaceutical companies are to blame When Donald Trump spoke about drug prices on 19 December, he struck a familiar note. Americans, he said, were paying far too much for medicines – and it was everyone else’s fault. There would be no talk of reining in private insurers or pharmaceutical profits. Instead, Trump blamed foreign governments for getting a better deal.
Open in Who Shared View Duplicates (5) Issue with article?

Constructing a single market for pharmaceuticals in the EU: what’s the price?

|
By Tineke Kleinhout-Vliek, Susi Geiger, Rob Hagendijk
| Cambridge University Press & Assessment
Pharmaceutical reform and market construction in the European Union ‘Today we add another central pillar to our European Health Union. We are putting forward proposals to ensure that medicines reach patients everywhere in Europe, in a timely and equitable fashion. It is a reform which ensures that Europe remains attractive for business, and our pharmaceutical industry a global innovation powerhouse. Building a single market for medicines is a necessity both for our citizens and our companies’.
Open in Who Shared Issue with article?
See all 11 licensed articles (13 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Susi

Contact Susi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified